SynthesisBMC public health2026
Determinants of contraceptive discontinuation among sexually active women in Nigeria: a systematic review.
Synthesis in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionContraceptive use is critical for improving reproductive health and reducing unintended pregnancies, yet many women discontinue its use despite the need for it. In Nigeria, the total fertility rate remains high at 4.8 children per woman, while modern contraceptive prevalence among women of reproductive age is only 17-20%, highlighting persistent gaps in family planning. This systematic review aimed to synthesize evidence on the prevalence, patterns, and determinants of contraceptive discontinuation among Nigerian women.
methodsA systematic review was conducted focusing on studies from Nigeria involving sexually active women aged 15-49 years who had previously used contraceptives. Multiple databases were searched using keywords for family planning, discontinuation, and Nigeria. Eligible observational, qualitative, and mixed-methods studies were screened and selected using the PRISMA framework. Data extraction included prevalence, method-specific discontinuation, and reasons for cessation. After screening 12,768 records and removing duplicates, 48 studies were included in the review.
resultsDiscontinuation rates varied by method type. Condoms were discontinued primarily due to behavioral factors, such as inconsistent use, discomfort, or misconceptions, with 12-month discontinuation rates around 17-18%. Oral contraceptives were discontinued within the first 12 months by 21-59% of users, largely due to side effects, daily regimen demands, and personal fertility intentions. Injectables showed discontinuation rates of 19.8-53.3%, mostly within the first 3-6 months, driven by side effects and the desire for pregnancy. Long-acting reversible contraceptives, including implants and intrauterine devices, had lower discontinuation rates (7%-42.9% at 12 months), though early discontinuation was associated with menstrual irregularities, desire for pregnancy, or method-specific side effects. Key determinants of discontinuation included side effects, fertility desires, spousal opposition, cultural or religious beliefs, and poor-quality counselling.
conclusionContraceptive discontinuation in Nigeria undermines the effectiveness of family planning programmes and contributes to unintended high fertility rates. Policymakers should strengthen national counselling standards, while donors should invest in provider training, follow-up systems, and commodity supply and implementers, including healthcare providers and non-governmental organizations should prioritize client-centered counselling, management of side effects, and community engagement to support sustained contraceptive use. Coordinated action across these levels is essential to reduce unmet need and improve reproductive health outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.